The Efficacy to Effectiveness Dilemma: Real World Evidence, Big Data and Digital Technology

Screen Shot 2016-02-26 at 9.32.11 PMThe Translational Research Program (TRP) and the Health Innovation Hub (H2i) present…

The Efficacy to Effectiveness Dilemma: Real World Evidence, Big Data and Digital Technology
with invited speaker

Dr. Vicki Seyfert-Margolis, Founder and CEO of My Own Med

Friday March 11, 10:00 – 11:30am

Peter Gilgan Centre for Research and Learning
686 Bay Street, 2nd floor, Event Room 1

RSVP for the talk

Followed by private workshops with Dr. Vicki Seyfert-Margolis — Apply for the workshops here

1:30pm – Entrepreneurship in the healthcare world: lessons learned, challenges and stories from the trenches
(Entrepreneurship focused workshop geared towards clients of h2i and other CLA)

2:30pm – Translational medicine: the valley of death redefined – now moved to implementation in the real world
(Translational and innovation focused workshop geared towards students of the TRP and other U of T students)


The Efficacy to Effectiveness Dilemma: Real World Evidence, Big Data & Digital Technology talk abstract:

Real world evidence and patient reported outcomes are fast becoming key aspects for late-stage clinical trials. The US FDA and the EMA have both been increasingly emphasizing patient-centered drug development and bridging the efficacy-to-effectiveness gap that exists between drug performance in trials versus real world practice. Furthermore, payment reform across the globe has necessitated efficacy validation, demonstrating that drugs perform in the real world and that they provide benefit, both as assessed by traditional endpoints as well as through improvements in patient quality of life. Big data and digital technology both are having a profound impact on how we measure impact of our interventions, but are we still missing key elements of understanding about health outcomes in the real world?

Read Dr. Vicki Seyfert-Margolis’ Bio

Follow and like us: